Active infection with torquetenovirus (TTV) has been associated with an increased severity of diseases in which inflammation plays a particularly important pathogenetic role. Here, we report that cloned DNA of a genogroup 4 TTV (ViPiSAL) is an activator of proinflammatory cytokine production by murine spleen cells and that the effect is mediated via toll-like receptor (TLR)9. The same DNA also increased the levels of proinflammatory cytokines induced by two well-characterized TLR9 stimulants. Finally, in silico analyses of the genomes of ViPiSAL and other TTVs revealed marked differences in the representation of CpG motifs known to be most effective at activating immune cells via TLR9. These findings demonstrate for the first time that at least one TTV isolate has the potential to stimulate and co-stimulate inflammatory responses.
Introduction
Torquetenovirus (TTV), the prototype of the anelloviruses, is characterized by a roughly spherical non-enveloped 30-to 32-nm capsid and a small, circular negative-sense single-stranded (ss) DNA genome. Different TTV isolates are heterogeneous both in genome size (∼3.5 to ∼3.9 kb) and in genome sequence (nucleotide [nt] diversity up to over 50%), which has led to their classification into 5 widely diverse genogroups and numerous genotypes. However, the genetic organization of TTV is well conserved. The coding region contains two major open reading frames (ORFs)-ORF1 of ∼2.6 kb encoding the nucleocapsid protein and a protein involved in DNA replication, ORF2 encoding a protein with putative phosphatase activity-and some poorly conserved small ORFs with unknown functions. The non-coding region (UTR) is relatively large, representing approximately 1/3 of the genome, and encompasses a short domain highly conserved among all anelloviruses, several regulatory elements believed to be important in viral replication, and, as salient feature, a stretch of 80 to 160 nt with unusually high G-C content (reviewed in Bendinelli and Maggi, 2005; Hino and Miyata, 2007; de Villiers and zur Hausen, 2009) .
The prevalence of TTV infection is well above 80% throughout the world (Hino and Miyata, 2007; Ninomiya et al., 2008; Okamoto, 2009) . Infection is acquired early in life or even in utero, and viremia persists for years or for life Maggi et al., 2003) . The virus is ubiquitous in the body, being readily detectable in nearly all organs and tissues Pollicino et al., 2003) . TTV loads in plasma and kinetics of replication are generally elevated, being in the order of those of other chronic viremia-producing viruses such as the human immunodeficiency and the hepatitis C viruses . Also, TTV is shed in abundance with many body materials, including saliva, nasal fluids, feces, genital secretions and breast milk (Matsubara et al., 2000; Maggi et al., 2003; Bendinelli and Maggi, 2005) . Finally, most people harbor a mixture of TTV genogroups and genotypes .
Although, there is probably no other known human virus as pervasive, pleomorphic, and polytropic as TTV, the attempts to find a direct causal link between TTV and human disease have so far been unsuccessful (reviewed in de Villiers and zur Hausen, 2009 ). This, however, does not exclude that TTV may harm the host in more subtle ways, for example by aggravating the course of diseases due to independent noxae. Indeed, studies have revealed interesting positive correlations between infection with specific TTV genogroups or especially active TTV replication and severity of certain diseases, including AIDS, neoplasia, asthma and rheumatoid arthritis (Shibayama et al., 2001; Pifferi et al., 2005; de Villiers et al., 2007; Maggi et al., 2004 Maggi et al., , 2007 Thom and Petrik, 2007) . Since inflammation is a particularly important component in many if not all these diseases, we considered it of interest to determine whether the DNA of TTV may represent a stimulus for the production of proinflammatory cytokines. In fact, recent studies have shown that, unlike that of mammals but similar to that of bacteria, the DNA of some viruses directly or indirectly activates a variety of cell types involved in immunity, including dendritic cells, macrophages and selected lymphocyte subpopulations, and drives the production of proinflammatory cytokines, including interferon (IFN)γ, interleukin (IL)6, and IL12 (Hochrein et al., 2004; Hayashi et al., 2006; Sato et al., 2006; Takeuchi and Akira, 2009 ). The effect is mainly if not solely due to unmethylated cytidyl guanosyl dinucleotides (CpG), which are relatively frequent in bacterial and viral DNA but uncommon in vertebrate genomes. In particular, to possess stimulatory activity (stimulatory CpG or CpG-S) unmethylated CpG needs to be in specific 6-mer sequence contexts, while unmethylated CpG in other sequence contexts is either inhibitory (CpG-I) or neutral, and CpG-S activity is mediated by members of the toll-like receptor (TLR) family, more precisely the endosomally localized TLR9 Kumagai et al., 2008a Kumagai et al., , 2008b Thompson and Iwasaki, 2008) . Using a genogroup 4 TTV, the present study shows for the first time that the DNA of TTV can induce immune cells to produce and secrete IFNγ, IL6 and IL12 and that the effect is mediated via TLR9.
Results

TTV DNA stimulates the expression of selected cytokine genes
Since the attempts to grow TTV in culture at levels that would permit DNA extraction from virions have so far failed, we used TTV DNA representing the entire viral genome amplified in a bacterial plasmid and denatured to render it ss. The DNA was amplified from the plasma of a patient with rheumatoid arthritis that, as determined with a panel of genogroup-specific PCR assays, had been found to be positive for a TTV (ViPiSAL, accession number: EU889253; ref. Maggi et al., 2007) , the complete sequence of which segregated within genogroup 4 (mean genetic distance from the other members of this group, 34%) and diverged from the other TTV genogroups by over 70%. In this experiment, mouse spleen cells were exposed ex vivo for 12 h to graded doses of TTV DNA and then analyzed for content in IFNγ, IL6, IL10, and IL12 mRNAs by reverse transcription real-time PCR assays using GAPDH RNA for normalization. This timing was selected because in preliminary experiments, it had provided the highest levels of stimulation for all the cytokine genes investigated over the 24 h of incubation that were explored. Positive controls were spleen cell cultures exposed to the well characterized TLR9 stimulant ODN1826, while negative controls were cells exposed to lipofectin alone or diluent alone. As shown by Fig. 1 , TTV DNA added alone at 3 different doses had no detectable effects on expression levels of the cytokine genes under test. However, when the same DNA was complexed with the transfecting agent lipofectin (TTV-lipo) before addition to the cultures, it produced a marked increase of IFNγ gene expression, a moderate increase of IL6 gene expression, and a modest increase of IL10 gene expression relative to the levels found in the negative control cultures. These effects were TTV DNA dosedependent with peak responses observed at the dose of 24 μg per well ( Fig. 1 ) and, as shown by Fig. 2 for IFNγ gene expression, were much greater than observed with a similar dose of salmon sperm DNA, an unrelated DNA known to be little or non stimulatory (Magnusson et al., 2001; Hasslung et al., 2003) . In contrast, TTV DNA regardless of whether complexed or not with lipofectin failed to increase the expression of IL12 (Fig. 1) . On the other hand, in a similar experiment TTV DNA also failed to stimulate IL4 RNA production, although control cultures exposed to Concanavalin A (ConA) showed a 100-fold or more increase in the expression of this cytokine (Fig. 3) .
TTV DNA stimulates the secretion of selected cytokines
In these experiments, we used a multiplex bead-based immunoassay to measure the levels of IFNγ, IL6, and IL4 protein in the supernatant of spleen cells cultures exposed to 24 μg TTV-lipo. As shown in Table 1 , at all time points investigated TTV-lipo induced levels of IFNγ and IL6 greatly enhanced relative to the ones produced by control cultures incubated with lipofectin alone. Consistent with the results obtained by examining cytokine RNAs, the increase in IFNγ production was more pronounced than the increase in IL6 production. Also consistent with the gene expression findings, TTV-lipo exerted no appreciable effects on IL4 production.
TTV DNA stimulation of cytokine expression is mediated by TLR9
Since it appeared possible that the activation of cytokine expression brought about by TTV DNA was mediated through one or more TLRs, we examined whether it might be blocked by pretreating the spleen cells with two distinct TLR inhibitors. The first compound used was chloroquine, which has long been regarded as an inhibitor of TLRs in general but, more recently, has been shown to be especially active on TLR9 (Lee et al., 2003) . As depicted by Fig. 4 , at the concentration used chloroquine had no detectable effects on spleen cell viability (trypan blue exclusion) but completely prevented the activation of IFNγ, IL6, and IL10 RNA production by 24 μg TTV-lipo. Furthermore, the inhibitory effect was confirmed by measuring the levels of IFNγ in the supernatant of the cultures (Table 2) .
Interestingly, consistent with current views on chloroquine specificity (Lee et al., 2003) , the control wells that were included in the above expression experiment showed that this compound effectively blocked triggering of cytokine RNA expression by ODN1826 but was much less active if at all when the stimulant was ConA, known to act through TLR9-independent mechanisms (Fig. 4) . Thus, taken together the results of the experiment strongly argued in favor of the possibility that TLR9 was a major if not the only mediator of TTV-lipo stimulation. To investigate this possibility further, we used the RNA interference strategy for specifically silencing TLR9. Spleen cells cultures were transfected with TLR9-specific siRNAs as described in Material and methods, then exposed to 24 μg TTV-lipo or to 5 μg ConA and 12 h later tested for IFNγ expression. While, as expected, the treatment reduced only marginally the activating effect of ConA, it reduced TTV-lipo activity by approximately 80% (Fig. 5) .
TTV DNA potencies the activity of other TLR9 stimulants
Given the above results, it was of interest to examine whether TTV DNA might also act in concert with other TLR9 stimulants at 
Table 1
Levels of selected cytokines in the supernatant of spleen cells exposed to TTV-lipo or lipofectin alone and measured at selected times of culture. enhancing cytokine gene expression. The TLR9 stimulants selected for these experiments were ODN1826 and Escherichia coli ssDNA. Fig. 6 depicts the results of a representative experiment in which different doses of TTV DNA, complexed or not with lipofectin, were added to spleen cell cultures treated with ODN1826. As shown, when ODN1826 was the only stimulant, IFNγ, IL6 and IL10 gene expression increased approximately 20-fold, and the addition of TTV DNA with no lipofectin increased this response only at the highest dose used (24 μg) and only very moderately. In contrast, a suboptimal dose of TTV-lipo (6 μg), but not lipofectin alone, increased the responses of spleen cells to ODN1826 and, in the case of IFNγ and IL6, the effect was very pronounced. The results with E. coli ssDNA, albeit less striking, went in the same direction. In this experiment, E. coli ssDNA was either present or absent, and TTV DNA was used at 1, 10 or 30 μg/well, while lipofectin was present in all the cultures. As shown by Fig. 7 , E. coli ssDNA and TTV DNA produced the expected stimulations of cytokine gene expression, and the combination of the two produced significantly augmented responses.
In silico analysis of the DNA of different TTVs as potential cytokines stimulants
Since different TTVs vary widely in nt composition and sequence, it is possible that they also differ in the ability to stimulate cytokine responses. This possibility was examined by scanning the genomes of different TTVs for published consensus CpG-S and CpG-I and, on the basis of their frequencies, calculating the so-called CpG index, which has been recently introduced to evaluate DNA molecules as putative cytokine stimulants regardless of their size, nt composition, and overall C+G content (Lundberg et al., 2003) . ViPiSAL, used in the above experiments, and 44 further isolates for which the full-length or near full-length sequence was present in GenBank and representative of all the 5 TTV genogroups currently recognized (minimum, 7 isolates per group) were evaluated. As shown in Table 3 , all exhibited substantially lower contents of total CpG motifs than expected based on random base usage. However, while the ratios between the observed and the expected frequencies of CpG-I were rather uniform throughout the isolates, in the case of CpG-S the same ratios were widely different, ranging between approximately 20 and 125. As a result, calculated CpG indexes varied extensively, ranging from greater than 18 (putatively stimulatory) to − 24 (putatively inhibitory). Variation was high even within the members of a same genogroup, but those in genogroup 4 were the most consistently stimulatory (Table 3 ). In particular, the differences between median CpG index of genogroup 4 and those of genogroups 3 and 5 were statistically significant at p = 0.0099 and 0.0051, respectively. Importantly, these differences were maintained also when the CpG indexes were calculated using only the segments of the GenBank sequences that could be aligned, thus excluding that the fact that the near fulllength sequences lacked small parts of the genome might affect the overall findings (p = 0.038 and p = 0.0036, respectively). Notably, ViPiSAL exhibited a moderately stimulatory CpG index (4.3).
Discussion
Prompted by observations that certain DNA viruses have the potential to stimulate immune cells to produce IFNγ and other proinflammatory cytokines through the unmethylated CpG motifs present in their genomes (Lundberg et al., 2003; Malmgaard, 2004; Basner-Tschakarjan et al., 2006; Gill et al., 2006; Guggemoos et al., 2008) , in this study we investigated whether such a property is shared by TTV. Spleen cells of BALB/c mice incubated with TTV-lipo (DNA of ViPiSAL, a genogroup TTV isolate, complexed with lipofectin) expressed increased levels of IFNγ, IL6, and IL10 RNAs, while the levels of IL4 and IL12 RNAs remained unchanged. In contrast, TTV DNA alone or lipofectin alone exerted no detectable effects. Lipofectin is known to spontaneously incorporate DNA, protecting it against nucleases and efficiently delivering it into a variety of cell types, including spleen cells (Felgner and Ringold, 1989) . It was thus concluded that the TTV DNA used can effectively activate proinflammatory gene transcription in immune cells, provided that it is associated with a substance capable of protecting and delivering it into the cells, that is of substituting for the viral capsid (Xu and Szoka, 1996) . Consistent with these findings, the stimulatory effect of TTVlipo on spleen cells was dependent on the dose of viral DNA incorporated in the liposomes and was reflected by increased concentrations of IFNγ and IL6, but not IL4 in the supernatant of the cultures relative to what observed with sister cultures exposed to lipofectin alone.
We subsequently performed two inhibition experiments to assess whether the above activity of TTV DNA was mediated by TLR9. Chloroquine, known to inhibit TLR9 activation due to its ability to block endosomal acidification, which is a prerequisite for TLR9-mediated recognition of unmethylated DNA and signaling (Latz et al., 2004; Rutz et al., 2004) , completely blocked the activation of IFNγ, IL6, and IL10 gene expression by TTV-lipo, and the effect was confirmed by measuring the concentration of IFNγ released in the culture supernatants. Also, a mixture of TLR9-specific siRNAs inhibited TTV-lipo induced activation of IFNγ RNA transcription by approximately 80%. Thus, collectively these findings clearly indicated that TTV DNA activity is mediated mainly, if not exclusively, through TLR9. This endocytic receptor, that is expressed in a variety of cell types and triggers signal cascades that culminate in proinflammatory cytokines secretion, was originally identified as a bacterial DNA receptor (Hemmi et al., 2000) but was later shown to be involved in innate sensing of some complex DNA viruses as well (Iacobelli-Martinez and Nemerow, 2007; Sorensen et al., 2008; Rasmussen et al., 2009 ). Furthermore, TLR9 is known to intervene in the induction of Th1 adaptive immune responses and in B cell proliferation (Latz et al., 2004; Takeshita et al., 2004; Kumagai et al., 2008a; Muller et al., 2008) .
Further experiments were aimed at assessing whether TTV DNA can modify the expression of proinflammatory cytokines induced by other stimuli and made use of two well-characterized TRL9 stimulants, the synthetic olideoxynucleotide ODN1826 and sheared E. coli ssDNA. A low dose of TTV-lipo (6 μg) markedly enhanced the expression of IFNγ, IL6, and IL10 induced in spleen cells by ODN1826, and a similar effect, although less pronounced, was seen with E. coli ssDNA. Interestingly, in the experiment with ODN1826 also a high dose of TTV DNA alone (24 μg) enhanced the response of spleen cells, albeit much less than a low dose of TTV-lipo. Thus, these findings indicated that TTV DNA has the ability to augment the production of proinflammatory cytokines triggered by other TLR9 stimuli and that for this effect the requirement for lipofectin may not be absolute. Additional investigations will be needed to establish whether TTV maintains this ability when its DNA is combined with increasing doses of such stimuli.
Finally, to obtain an indication of how extensively the genetic diversity of TTV might reflect on the ability of its DNA to modulate proinflammatory cytokine production, we made a computer analysis and calculated the CpG index of 45 isolates belonging to all 5 TTV genogroups, including ViPiSAL. In analogy with the great majority of small vertebrate viruses (Karlin et al., 1994) , a common feature of all the TTVs examined was a low prevalence of CpG motifs relative to what is expected based on a random base usage, which might suggest a common evolutive interest at suppressing the occurrence of these motifs (Wikstrom et al., 2007; Hoelzer et al., 2008) . The CpG index was recently introduced to predict in silico the efficacy of DNAs as lymphoid cell stimulants on the basis of the consensus CpG-S and CpG-I motifs they contain (Lundberg et al., 2003) . Although the reliability of this index at predicting the actual stimulatory activity of DNAs in in vivo situations has yet to be validated, there is no doubt that it provides a reasonable comparison of their contents in CpG-S and CpG-I motifs, considered major factors, albeit not the only ones, in determining such activity (Stacey et al., 2003) . While ViPiSAL a Ratio between the frequency of CpG motifs observed and the one expected on the basis of genomic G + C content, if the bases were used randomly. b No. of CpG hexamer motifs (NNCGNN) normalized to 1 kb and the one expected on the basis of genomic G + C content, if the bases were used randomly. c Ratio between the frequency of total CpG hexamer motifs (NNCGNN). d Consensus CpG-S (RRCGYY) and CpG-I (NCCGNN and NNCGRN) deduced by published papers (Krieg et al., 1998; Lundberg et al., 2003) . e Calculated by the formula under Materials and methods. A positive value is indicative of a putatively stimulatory genome and a negative value of a putatively inhibitory genome. f Calculated using the entire full-length or near full-length TTV sequences as found in GenBank. g Calculated using only the segments of the GenBank sequences that could be aligned. h Median. In parenthesis, the range of value.
exhibited a moderately stimulatory value, the other CpG indexes varied greatly ranging from putatively markedly stimulatory to putatively markedly inhibitory values. CpG indexes varied widely even among TTVs belonging to a same genogroup; however, those of genogroup 4 were the most consistently stimulatory. Notably, similar calculations performed on deduced ss antigenomes and doublestranded replicative forms of the 45 isolates gave similarly varied CpG indexes, but those of genogroup 4 were again the most stimulatory (data not shown). Based on these findings, it would therefore appear that different TTVs can vary widely with regard to the capacity to activate immune cells, a circumstance that, if confirmed experimentally, would make it extremely difficult predicting the impact the variety of TTVs and mixtures of TTVs harbored by different people may exert on immune cell functions. It is, however, noteworthy that genogroup 4 TTV, which is relatively infrequent in healthy individuals, was found at increased rates in patients with rheumatoid arthritis and in children with particularly severe acute respiratory diseases, two diseases in which the extent of inflammation contributes greatly to clinical severity (Maggi et al., 2003 (Maggi et al., , 2007 .
In conclusion, these results represent the first evidence that the DNA of at least one TTV can activate TLR9, thereby driving immune cells to synthesize and secrete proinflammatory cytokines. Since TTV is known to extensively infiltrate and possibly replicate in many tissues Pollicino et al., 2003) , continuous or intermittent TLR9 stimulation by its DNA is likely to occur, thus supporting the notion that TTV infection may significantly impact on development and severity of diseases in which inflammation is an important determinant of tissue damage. A limitation of this study is that, due to the existing difficulties in growing TTV in vitro, it used viral DNA cloned in a bacterial plasmid, thus excluding the possible intervention of the cellular methyltransferases, which extensively methylate cytosine in vertebrate cell DNA (Hermann et al., 2004) , at attenuating the stimulatory potential of TTV DNA. The methylation status of natural TTV DNA is unknown (Hoelzer et al., 2008) , but evidence has recently been presented that the genome of another ssDNA virus, porcine circovirus 2, is scarcely methylated (Wikstrom et al., 2007) . Indirect support to the idea that the immunostimulatory activity of TTV DNA can be biologically relevant also comes from the recent observation that the ORF2 protein of TTV inhibits cell production of proinflammatory mediators in response to lipopolysaccharide by down-regulating nuclear factor kB, known to be centrally involved in multiple signal transduction pathways that activate inflammation, including those triggered by TLR9 (Zheng et al., 2007) . Conceivably, this ORF2 activity, as well as the generalized suppression of CpG motifs in TTV genomes discussed above, may have evolved to counteract the stimulatory effect of TTV DNA on innate and adaptive immune responses, an effect that would otherwise likely reduce TTV ability to evade recognition and persist in infected hosts. That different products of TTV can impact differently on the production of soluble mediators is not surprising in view of what observed with other viral infections (Sorensen et al., 2008; Russell, 2009 ) and may reflect the fact that they are recognized by different receptors and/or interact with different molecular pathways. Further studies aimed at understanding the physiopathological implications of TTV infections are clearly warranted.
Materials and methods
TTV DNA preparation
The strategy for amplifying the complete TTV isolate (3672 nt) was as follows: first, a segment of 3204 nt (nt 403 to 3606) encompassing most of the coding region and part of the UTR was amplified using an inverse PCR with UTR primers highly conserved among the genogroup 4 sequences in GenBank at the time of the study; subsequently, the remaining part of the viral genome (nt 3607 to 402) was amplified with a nested PCR using primers specifically designed on ViPiSAL. The two amplicons were then cloned into pDrive Cloning Vector (Qiagen, Hilden, Germany) grown in TOP10 E. coli cells (Invitrogen, Carlsband, CA) , extracted with GenElute Endotoxin-free Plasmid Maxi-Prep Kit (Sigma Aldrich, St. Louis, MO), excised by restriction enzyme digestions, and purified by electrophoresis on 1.5% agarose gel. The inserts were then extracted from the gels, purified, concentrated in endotoxin-free water, and quantified spectrophotometrically. Finally, the two inserts were mixed in equimolar proportions and stored in aliquots at −20°C until used. Endotoxin contamination of the preparation was excluded by a Limulus amebocyte assay (LAL; PBI, Milan, Italy) having a lower detection limit of 0.03 endotoxin units per ml, while plasmid contamination was excluded by PCR amplifications using primers specifically designed to detect selected parts of the vector. Denaturation was carried out immediately before DNA use by boiling for 10 min, followed by cooling on ice for 5 min. The two amplicons were also used to obtain the complete sequence of the TTV isolate by sequencing on the ABI 3100 Genetic Analyzer (Applied Biosystem, Forster City, CA).
TLR9 ligands and other stimulants
The TLR9 ligands used as positive controls included the synthetic immunostimulatory oligodeoxynucleotide ODN1826 (5'-TCCATGAcgTTCCTGAcgTT-3'), which is protected against degradation by the nuclease-resistant bases phosphorothioate and phosphodiesters (indicated by lower and capital letters, respectively; Invivogen, San Diego, CA), and E. coli DNA (100 μg/ml) provided as sheared ssDNA fragments complexed with lipid-based transfection reagent (InvivoGen). The ability of these reagents to activate TLR9 has been established previously (Bauer et al., 2001) . All compounds were dissolved in ultrapure endotoxin-free water according to the manufacturer's recommendations and then stored in aliquots at −20°C until use. For cell stimulation, ODN1826 and E. coli DNA were used at the final concentrations of 6 and 10 μg per ml, respectively, throughout the study. ConA (Sigma Aldrich) was used as TLR9-independent stimulus at 5 μg/ml (final concentration). Salmon sperm DNA (InvivoGen) was dissolved 1 mg/ml in pyrogen-free water, sheared, reduced ss before use as described above, and used as an unrelated DNA control in TLR9 induction experiments. None of these preparations exhibited detectable endotoxin as determined by the LAL assay.
Stimulation of spleen cells ex vivo
Spleens were obtained aseptically from two 8-to 10-week-old inbred BALB/c mice reared at our animal house. Spleen cells were put in single-cell suspension using sterile dissection tools, washed 3 times in abundant phosphate-buffered saline, counted, and resuspended in RPMI 1640 medium (BioWhittaker; Cambrex Bioscience, Verviers, Belgium) supplemented with 1% glutamine and 10% fetal calf serum (complete medium). The stimulation tests were carried out by exposing 3 × 10 6 cells in 1 ml of complete medium in 24-well plates at 37°C in 5% CO 2 to the indicated concentrations of TTV DNA and of the positive and negative control stimulants. At the end of the incubation period, cells and culture supernatants were transferred to centrifugation tubes and separated at 500g for 10 min. The cells were then stored as such at − 80°C, and the supernatants filtered through 0.2-μm filters and stored at −20°C until assayed for content in cytokine RNAs and proteins, respectively. Each reagent was assayed in triplicate wells in at least two independent experiments, and the wells were tested individually. Based on the results of pilot experiments in which spleen cells were stimulated using the same protocol with ODN1826 for varying periods of time, cytokine RNAs were measured 12 h post stimulation. The cytokines released were instead measured in supernatants collected at 8, 16, and 24 h.
Lipofectin
In most stimulation experiments, TTV DNA was used complexed with the cationic liposomes lipofectin (TTV-lipo). These complexes were generated as described earlier (Hasslung et al., 2003) before adding to the spleen cell cultures. In brief, lipofectin (Invitrogen) was diluted 1:4 with medium containing no serum and, after 45 min at room temperature (r.t.), mixed with the desired amount of TTV DNA, also diluted in serum-free medium. After additional 15 min at r.t., the mixture was added to the wells containing the test spleen cells. Wells containing similarly prepared lipofectin alone but no TTV DNA served as controls.
Measurement of cytokine gene expression
Total RNA extracted from the spleen cells was reverse-transcribed into cDNA, which was then used for quantitating cytokine and GAPDH RNAs using real-time PCR assays. The assays were performed on ABI PRISM 7700 (Applied Biosystem) using commercially available kits with primers and probes specific for each murine cytokine (TaqMan Gene Expression assays; Applied Biosystem). All samples were amplified in triplicate, and negative PCR controls with no cDNA template and total RNA without prior reverse transcription were included in each round of tests. The relative expression ratio of cytokine genes was calculated with the Relative Expression Software Tool (REST; ref. Pfaffl et al., 2002) , which allows for a relative quantification between groups and a normalization of the target genes with a reference gene. This software calculates the relative expression ratio (R) of a given cytokine gene on the basis on its real-time PCR efficiency (E) and the crossing point (Cp) difference (Δ) of an unknown sample versus a control (i.e. untreated cells). Target gene expression is normalized against GAPDH, which in preliminary experiments with ODN1826 and throughout the study was found not to be appreciably modulated. The formula is: R = E target ΔCp target (mean control-mean sample) /
E reference
ΔCp reference (mean control-mean sample)
.
Measurement of cytokine proteins
Cell-free-supernatants collected from the spleen cell cultures were assayed for simultaneous quantification of murine IFNγ, IL4, and IL6 by using a commercial multiplex bead-based immunoassay kit (BioPlex system; BioRad). Cytokine assays were performed in duplicate as described by the manufacturer's protocol, and each well was assayed twice. Every experiment was repeated at least twice.
Inhibition of TLR9 activity
In some experiments, prior to use in the stimulation assays the spleen cells were treated with chloroquine or transfected with TLR9-specific siRNAs. The first treatment was carried out by incubating the cells with 10 μM chloroquine (InvivoGen) in the dark for 10 min. The second was carried out exposing the cells to a mixture of commercial siRNAs (MmTLR9_1HPsiRNA and MmTLR9_2HPsiRNA; Qiagen) at final concentration 400 nM, according to manufacturer's protocol. Briefly, the siRNAs were diluted in serum-free RPMI 1640, mixed with HiPerfect Transfection Reagent, incubated at r.t. for 5-10 min to allow the formation of transfection complexes, and finally added to wells plated with 2 × 10 6 spleen cells suspended in 100 μl complete medium.
After 2 h at 37°C, 500 μl of complete medium were added, and, prior to the addition of TTV DNA or control stimuli, the cultures further incubated for 24 h to maximize TLR9 gene expression inhibition.
In silico analysis of TTV genomes for CpG index calculation
ViPiSAL and additional 44 full-length or near full-length TTV sequences present in GenBank at the time of writing and representative of the 5 TTV genogroups currently recognized were subjected to computer-based analysis for determining the frequency of published consensus CpG-S and CpG-I 6-mer motifs (Krieg et al., 1998; Lundberg et al., 2003) . The data thus generated were used to calculate the CpG index of each sequence using the formula: (ρ stimolatory − ρ inhibitory ) × (CpG/kb) × ρCpG, where the difference between the ratio (ρ, observed frequency versus theoretical frequency) of stimulatory and inhibitory CpG hexamer motifs was multiplied by the total number of CpG motifs present in the TTV genome under study (normalized to 1 kb) and the overall frequency of CpG motifs (Lundberg et al., 2003) . To exclude possible distortions deriving from the fact that some GenBank sequences were near full-length, CpG indexes were also calculated on the segments of the same sequences that could be aligned (varying in length between 3.326 and 3.653 nt).
Statistical analyses
Differences between continuous variables were analyzed by the Student's t test and Mann-Whitney test. Statistical significance of differences in cytokine mRNA expression was determined using REST, which allows group-wise comparison and statistical analysis of relative expression results in real-time PCR. A level of 0.05 was taken to indicate statistical significance.
